Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06082687 · ClinicalTrials.gov registry record
De-identified Human Tissue Project
A clinical trial of Tissue, sponsored by University of Central Florida.
- Recruiting
- Registry status
- 1,000,000
- Enrollment target
- 1
- Study location
NCT06082687: Recruiting study of Tissue, sponsored by University of Central Florida.
NCT06082687 is a study of Tissue that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 1,000,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06082687, a study of Tissue, is actively recruiting participants, sponsored by University of Central Florida.
- RECRUITING
- Registry status
- 1,000,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational medical research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or treating disease or disease symptoms. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.
Primary Outcome
The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology. Frequently, these studies require human tissue for testing of assays and devices.
Conditions Studied
Study Locations (1)
Florida
- University of Central Florida - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000,000 participants |
| Start Date | 2022-09-14 |
| Est. Completion | 2027-09 |
What NCT06082687 shows while recruiting
NCT06082687 is an observational study that tracks outcomes without assigning an intervention. Its 1,000,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Tissue appearing as the primary indexed condition, and to 0 interventions.
NCT06082687 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06082687 about?
NCT06082687 is a clinical study titled "De-identified Human Tissue Project". Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational medical research for the purpose of understanding human disease and developing innovative methods for diagnos...
What is the current status of trial NCT06082687?
This trial is currently recruiting. The enrollment target is 1,000,000 participants. The study started on 2022-09-14. Estimated completion is 2027-09.
What conditions does trial NCT06082687 study?
This clinical trial studies the following conditions: Tissue.
Who is sponsoring clinical trial NCT06082687?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06082687 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05066763 · 1,000,000 participants
Parkinson's Foundation Surveys
- NCT07075341 · 1,000,000 participants
Healthy Living BEYOND Weight Study
- NCT07224685 · 1,000,000 participants
A Study of Mayo Clinic CV Research Heart & Voice Study
- NCT06029933 · 960,000 participants
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI